{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T18:28:28Z","timestamp":1794594508628,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2022,8,1]]},"DOI":"10.1038\/s41416-022-01826-2","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T11:10:05Z","timestamp":1651835405000},"page":"379-382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":138,"title":["Cancer cachexia: a nutritional or a systemic inflammatory syndrome?"],"prefix":"10.1038","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6889-6240","authenticated-orcid":false,"given":"Josh","family":"McGovern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5272-5906","authenticated-orcid":false,"given":"Ross D.","family":"Dolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Skipworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Laird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4260-5334","authenticated-orcid":false,"given":"Donald C.","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,6]]},"reference":[{"key":"1826_CR1","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Prim. 2018;4:17105.","journal-title":"Nat Rev Dis Prim"},{"key":"1826_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489\u201395.","journal-title":"Lancet Oncol"},{"key":"1826_CR3","unstructured":"Medicine NLo. Cancer Cachexia. NIH; 2022 [cited 2022 March]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=cancer+cachexia."},{"key":"1826_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clnu.2018.08.002","volume":"38","author":"T Cederholm","year":"2019","unstructured":"Cederholm T, Jensen GL, Correia M, Gonzalez MC, Fukushima R, Higashiguchi T, et al. GLIM criteria for the diagnosis of malnutrition\u2014a consensus report from the global clinical nutrition community. Clin Nutr. 2019;38:1\u20139.","journal-title":"Clin Nutr"},{"key":"1826_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MCO.0b013e32832a7902","volume":"12","author":"DC McMillan","year":"2009","unstructured":"McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 2009;12:223\u20136.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1826_CR6","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N. Engl J Med. 1999;340:448\u201354.","journal-title":"N. Engl J Med"},{"key":"1826_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1017\/S0029665108007131","volume":"67","author":"DC McMillan","year":"2008","unstructured":"McMillan DC. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc. 2008;67:257\u201362.","journal-title":"Proc Nutr Soc"},{"key":"1826_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semcdb.2016.02.009","volume":"54","author":"TA Zimmers","year":"2016","unstructured":"Zimmers TA, Fishel ML, Bonetto A. STAT3 in the systemic inflammation of cancer cachexia. Semin Cell Dev Biol. 2016;54:28\u201341.","journal-title":"Semin Cell Dev Biol"},{"key":"1826_CR9","doi-asserted-by":"publisher","first-page":"693458","DOI":"10.1155\/2009\/693458","volume":"2009","author":"KM Fox","year":"2009","unstructured":"Fox KM, Brooks JM, Gandra SR, Markus R, Chiou CF. Estimation of cachexia among cancer patients based on four definitions. J Oncol. 2009;2009:693458.","journal-title":"J Oncol"},{"key":"1826_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.clnu.2006.01.020","volume":"25","author":"J Arends","year":"2006","unstructured":"Arends J, Bodoky G, Bozzetti F, Fearon K, Muscaritoli M, Selga G, et al. ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin Nutr. 2006;25:245\u201359.","journal-title":"Clin Nutr"},{"key":"1826_CR11","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","volume":"83","author":"KC Fearon","year":"2006","unstructured":"Fearon KC, Voss AC, Hustead DS. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr. 2006;83:1345\u201350.","journal-title":"Am J Clin Nutr"},{"key":"1826_CR12","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","volume":"27","author":"WJ Evans","year":"2008","unstructured":"Evans WJ, Morley JE, Argil\u00e9s J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr. 2008;27:793\u20139.","journal-title":"Clin Nutr"},{"key":"1826_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","volume":"29","author":"M Muscaritoli","year":"2010","unstructured":"Muscaritoli M, Anker SD, Argil\u00e9s J, Aversa Z, Bauer JM, Biolo G, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) \u201ccachexia-anorexia in chronic wasting diseases\u201d and \u201cnutrition in geriatrics\u201d. Clin Nutr. 2010;29:154\u20139.","journal-title":"Clin Nutr"},{"key":"1826_CR14","doi-asserted-by":"publisher","first-page":"e0193693","DOI":"10.1371\/journal.pone.0193693","volume":"13","author":"S Gray","year":"2018","unstructured":"Gray S, Axelsson B. The prevalence of deranged C-reactive protein and albumin in patients with incurable cancer approaching death. PLoS ONE. 2018;13:e0193693.","journal-title":"PLoS ONE"},{"key":"1826_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1200\/JCO.2014.56.1894","volume":"33","author":"L Martin","year":"2015","unstructured":"Martin L, Senesse P, Gioulbasanis I, Antoun S, Bozzetti F, Deans C, et al. Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol. 2015;33:90\u20139.","journal-title":"J Clin Oncol"},{"key":"1826_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/jcsm.12499","volume":"11","author":"L Daly","year":"2020","unstructured":"Daly L, Dolan R, Power D, N\u00ed Bhuachalla \u00c9, Sim W, Fallon M, et al. The relationship between the BMI-adjusted weight loss grading system and quality of life in patients with incurable cancer. J Cachexia Sarcopenia Muscle. 2020;11:160\u20138.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1826_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57\u201370.","journal-title":"Cell"},{"key":"1826_CR18","doi-asserted-by":"publisher","first-page":"e000097","DOI":"10.1136\/bmjgast-2016-000097","volume":"3","author":"G Vanhoutte","year":"2016","unstructured":"Vanhoutte G, van de Wiel M, Wouters K, Sels M, Bartolomeeussen L, De Keersmaecker S, et al. Cachexia in cancer: what is in the definition? BMJ Open Gastroenterol. 2016;3:e000097.","journal-title":"BMJ Open Gastroenterol"},{"key":"1826_CR19","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.clnu.2017.06.017","volume":"36","author":"J Arends","year":"2017","unstructured":"Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36:1187\u201396.","journal-title":"Clin Nutr"},{"key":"1826_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.clnu.2016.09.004","volume":"36","author":"T Cederholm","year":"2017","unstructured":"Cederholm T, Barazzoni R, Austin P, Ballmer P, Biolo G, Bischoff SC, et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr. 2017;36:49\u201364.","journal-title":"Clin Nutr"},{"key":"1826_CR21","doi-asserted-by":"publisher","first-page":"100092","DOI":"10.1016\/j.esmoop.2021.100092","volume":"6","author":"J Arends","year":"2021","unstructured":"Arends J, Strasser F, Gonella S, Solheim TS, Madeddu C, Ravasco P, et al. Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines(\u2606). ESMO Open. 2021;6:100092.","journal-title":"ESMO Open"},{"key":"1826_CR22","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1200\/JCO.2015.65.7742","volume":"34","author":"BJ Laird","year":"2016","unstructured":"Laird BJ, Fallon M, Hjermstad MJ, Tuck S, Kaasa S, Klepstad P, et al. Quality of life in patients with advanced cancer: differential association with performance status and systemic inflammatory response. J Clin Oncol. 2016;34:2769\u201375.","journal-title":"J Clin Oncol"},{"key":"1826_CR23","doi-asserted-by":"publisher","first-page":"5456","DOI":"10.1158\/1078-0432.CCR-13-1066","volume":"19","author":"BJ Laird","year":"2013","unstructured":"Laird BJ, Kaasa S, McMillan DC, Fallon MT, Hjermstad MJ, Fayers P, et al. Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system. Clin Cancer Res. 2013;19:5456\u201364.","journal-title":"Clin Cancer Res"},{"key":"1826_CR24","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/jcsm.12756","volume":"12","author":"L Martin","year":"2021","unstructured":"Martin L, Muscaritoli M, Bourdel-Marchasson I, Kubrak C, Laird B, Gagnon B, et al. Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi-cohort analysis. J Cachexia Sarcopenia Muscle. 2021;12:1189\u2013202.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1826_CR25","doi-asserted-by":"crossref","unstructured":"Abbass T, Dolan RD, Laird BJ, McMillan DC. The relationship between imaging-based body composition analysis and the systemic inflammatory response in patients with cancer: a systematic review. Cancers. 2019;11:1304.","DOI":"10.3390\/cancers11091304"},{"key":"1826_CR26","doi-asserted-by":"crossref","unstructured":"McGovern J, Dolan RD, Horgan PG, Laird BJ, McMillan DC. Computed tomography-defined low skeletal muscle index and density in cancer patients: observations from a systematic review. J Cachexia Sarcopenia Muscle. 2021;12:1408\u201317.","DOI":"10.1002\/jcsm.12831"},{"key":"1826_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","volume":"17","author":"JS Temel","year":"2016","unstructured":"Temel JS, Abernethy AP, Currow DC, Friend J, Duus EM, Yan Y, et al. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol. 2016;17:519\u201331.","journal-title":"Lancet Oncol"},{"key":"1826_CR28","doi-asserted-by":"publisher","first-page":"e200663","DOI":"10.1001\/jamanetworkopen.2020.0663","volume":"3","author":"M Merker","year":"2020","unstructured":"Merker M, Felder M, Gueissaz L, Bolliger R, Tribolet P, K\u00e4gi-Braun N, et al. Association of baseline inflammation with effectiveness of nutritional support among patients with disease-related malnutrition: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2020;3:e200663.","journal-title":"JAMA Netw Open"},{"key":"1826_CR29","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","volume":"15","author":"CI Diakos","year":"2014","unstructured":"Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15:e493\u2013503.","journal-title":"Lancet Oncol"},{"key":"1826_CR30","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/bjc.2014.90","volume":"110","author":"CS Roxburgh","year":"2014","unstructured":"Roxburgh CS, McMillan DC. Cancer and systemic inflammation: treat the tumour and treat the host. Br J Cancer. 2014;110:1409\u201312.","journal-title":"Br J Cancer"},{"key":"1826_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16955-5","volume":"7","author":"RD Dolan","year":"2017","unstructured":"Dolan RD, Lim J, McSorley ST, Horgan PG, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis. Sci Rep. 2017;7:16717.","journal-title":"Sci Rep."},{"key":"1826_CR32","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.critrevonc.2017.06.002","volume":"116","author":"RD Dolan","year":"2017","unstructured":"Dolan RD, McSorley ST, Horgan PG, Laird B, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: Systematic review and meta-analysis. Crit Rev Oncol Hematol. 2017;116:134\u201346.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1826_CR33","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.critrevonc.2018.09.016","volume":"132","author":"RD Dolan","year":"2018","unstructured":"Dolan RD, Laird BJA, Horgan PG, McMillan DC. The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer: a systematic review. Crit Rev Oncol Hematol. 2018;132:130\u20137.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1826_CR34","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/ncb3015","volume":"16","author":"SS McAllister","year":"2014","unstructured":"McAllister SS, Weinberg RA. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol. 2014;16:717\u201327.","journal-title":"Nat Cell Biol"},{"key":"1826_CR35","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/MCO.0b013e328352a895","volume":"15","author":"N MacDonald","year":"2012","unstructured":"MacDonald N. Terminology in cancer cachexia: importance and status. Curr Opin Clin Nutr Metab Care. 2012;15:220\u20135.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1826_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.21037\/apm.2018.08.05","volume":"8","author":"E Del Fabbro","year":"2019","unstructured":"Del Fabbro E. Combination therapy in cachexia. Ann Palliat Med. 2019;8:59\u201366.","journal-title":"Ann Palliat Med"},{"key":"1826_CR37","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/jcsm.12201","volume":"8","author":"TS Solheim","year":"2017","unstructured":"Solheim TS, Laird BJA, Balstad TR, Stene GB, Bye A, Johns N, et al. A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer. J Cachexia Sarcopenia Muscle. 2017;8:778\u201388.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1826_CR38","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1136\/bmjspcare-2017-001440","volume":"8","author":"TS Solheim","year":"2018","unstructured":"Solheim TS, Laird BJA, Balstad TR, Bye A, Stene G, Baracos V, et al. Cancer cachexia: rationale for the MENAC (multimodal-exercise, nutrition and anti-inflammatory medication for cachexia) trial. BMJ Support Palliat Care. 2018;8:258\u201365.","journal-title":"BMJ Support Palliat Care"},{"key":"1826_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","volume":"16","author":"KC Fearon","year":"2012","unstructured":"Fearon KC, Glass DJ, Guttridge DC. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab. 2012;16:153\u201366.","journal-title":"Cell Metab"},{"key":"1826_CR40","first-page":"157","volume":"5","author":"N MacDonald","year":"2007","unstructured":"MacDonald N. Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative\/supportive care. J Supportive Oncol. 2007;5:157\u201362.","journal-title":"J Supportive Oncol"},{"key":"1826_CR41","doi-asserted-by":"crossref","unstructured":"Patton R, Paval DR, McDonald JJ, Brown D, Gallagher IJ, Skipworth RJE, et al. Relationship between cytokines and symptoms in people with incurable cancer: a systematic review. Crit Rev Oncol\/hematol. 2021;159:103222.","DOI":"10.1016\/j.critrevonc.2021.103222"},{"key":"1826_CR42","doi-asserted-by":"publisher","first-page":"e17019","DOI":"10.1097\/MD.0000000000017019","volume":"98","author":"RD Dolan","year":"2019","unstructured":"Dolan RD, Laird BJA, Klepstad P, Kaasa S, Horgan PG, Paulsen \u00d8, et al. An exploratory study examining the relationship between performance status and systemic inflammation frameworks and cytokine profiles in patients with advanced cancer. Medicine. 2019;98:e17019.","journal-title":"Medicine"},{"key":"1826_CR43","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.immuni.2017.08.009","volume":"47","author":"GS Hotamisligil","year":"2017","unstructured":"Hotamisligil GS. Foundations of immunometabolism and implications for metabolic health and disease. Immunity. 2017;47:406\u201320.","journal-title":"Immunity."},{"key":"1826_CR44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3109\/0284186X.2012.724536","volume":"52","author":"TS Solheim","year":"2013","unstructured":"Solheim TS, Fearon KC, Blum D, Kaasa S. Non-steroidal anti-inflammatory treatment in cancer cachexia: a systematic literature review. Acta Oncol. 2013;52:6\u201317.","journal-title":"Acta Oncol"},{"key":"1826_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.critrevonc.2016.03.011","volume":"101","author":"ST McSorley","year":"2016","unstructured":"McSorley ST, Horgan PG, McMillan DC. The impact of preoperative corticosteroids on the systemic inflammatory response and postoperative complications following surgery for gastrointestinal cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2016;101:139\u201350.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1826_CR46","doi-asserted-by":"publisher","first-page":"e000597","DOI":"10.1136\/esmoopen-2019-000597","volume":"5","author":"N Burdett","year":"2020","unstructured":"Burdett N, Desai J. New biomarkers for checkpoint inhibitor therapy. ESMO Open. 2020;5:e000597.","journal-title":"ESMO Open"},{"key":"1826_CR47","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S2213-2600(21)00139-9","volume":"9","author":"F Angriman","year":"2021","unstructured":"Angriman F, Ferreyro BL, Burry L, Fan E, Ferguson ND, Husain S, et al. Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context. Lancet Respir Med. 2021;9:655\u201364.","journal-title":"Lancet Respir Med"},{"key":"1826_CR48","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/ajcn\/nqx071","volume":"108","author":"ST McSorley","year":"2018","unstructured":"McSorley ST, Talwar D, McMillan DC. Comment on the biomarkers reflecting inflammation and nutritional determinants of anemia (BRINDA) project. Am J Clin Nutr. 2018;108:204\u20135.","journal-title":"Am J Clin Nutr"},{"key":"1826_CR49","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.clnu.2019.12.024","volume":"39","author":"RD Dolan","year":"2020","unstructured":"Dolan RD, Daly L, Sim WMJ, Fallon M, Ryan A, McMillan DC, et al. Comparison of the prognostic value of ECOG-PS, mGPS and BMI\/WL: implications for a clinically important framework in the assessment and treatment of advanced cancer. Clin Nutr. 2020;39:2889\u201395.","journal-title":"Clin Nutr"},{"key":"1826_CR50","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.clnesp.2020.08.003","volume":"40","author":"T Abbass","year":"2020","unstructured":"Abbass T, Dolan RD, MacLeod N, Horgan PG, Laird BJ, McMillan DC. Comparison of the prognostic value of MUST, ECOG-PS, mGPS and CT derived body composition analysis in patients with advanced lung cancer. Clin Nutr ESPEN. 2020;40:349\u201356.","journal-title":"Clin Nutr ESPEN"},{"key":"1826_CR51","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.3332\/ecancer.2021.1258","volume":"15","author":"PC Elwood","year":"2021","unstructured":"Elwood PC, Morgan G, Delon C, Protty M, Galante J, Pickering J, et al. Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers. Ecancermedicalscience. 2021;15:1258.","journal-title":"Ecancermedicalscience."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01826-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01826-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01826-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:00:34Z","timestamp":1744200034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01826-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,6]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,8,1]]}},"alternative-id":["1826"],"URL":"https:\/\/doi.org\/10.1038\/s41416-022-01826-2","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,6]]},"assertion":[{"value":"6 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The following review was conducted in accordance with the declaration of Helsinki. Ethical approval was not required for this study as this was a systematic review of published data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}